Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study

被引：0
|
作者：
Tito R. Mendoza
Kenneth L. Kehl
Oluwatosin Bamidele
Loretta A. Williams
Qiuling Shi
Charles S. Cleeland
George Simon
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Symptom Research
[2] The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine
[3] Dana-Farber Cancer Institute,Division of Population Sciences
[4] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head & Neck Medical Oncology
来源：
Supportive Care in Cancer | 2019年 / 27卷
关键词：
Lung cancer; Symptoms; Interference; Patient-reported outcomes; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3439 / 3447
页数：8
相关论文
共 50 条
  • [1] Assessment of baseline symptom burden in treatment-naive patients with lung cancer: an observational study
    Mendoza, Tito R.
    Kehl, Kenneth L.
    Bamidele, Oluwatosin
    Williams, Loretta A.
    Shi, Qiuling
    Cleeland, Charles S.
    Simon, George
    SUPPORTIVE CARE IN CANCER, 2019, 27 (09) : 3439 - 3447
  • [2] Assessment of Baseline Symptom Burden in Treatment-Naive Patients with Lung Cancer
    Mendoza, T.
    Simon, G.
    Kehl, K.
    Bamidele, O.
    Williams, L.
    Cleeland, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1879 - S1879
  • [3] Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients
    Johnny M. Hoang
    Navneet Upadhyay
    Dozie N. Dike
    Jaekyu Lee
    Michael L. Johnson
    Charles S. Cleeland
    Tito Mendoza
    Hua Chen
    Meghana V. Trivedi
    Supportive Care in Cancer, 2020, 28 : 1809 - 1816
  • [4] Initiating the antiretroviral therapy in treatment-naïve patients
    Elisabeta Benea
    Raluca Jipa
    Cozmina Andrei
    Mariana Mărdărescu
    Eliza Manea
    Iulia Niculescu
    Șerban Benea
    Ruxandra Moroti
    Adriana Hristea
    BMC Infectious Diseases, 14 (Suppl 7)
  • [5] Optimizing therapy in treatment-naïve genotype 1 patients
    Agudelo E.Z.
    Terrault N.A.
    Current Hepatitis Reports, 2008, 7 (2) : 64 - 71
  • [6] A biopsy-based Immunoscore in patients with treatment-naïve resectable gastric cancer
    Soeratram, Tanya T. D.
    Beentjes, Isis
    Egthuijsen, Jacqueline M. P.
    Mookhoek, Aart
    Lange, Marilyne M.
    Meershoek-Klein Kranenbarg, Elma
    Hartgrink, Henk H.
    van de Velde, Cornelis J. H.
    Ylstra, Bauke
    van Laarhoven, Hanneke W. M.
    van Grieken, Nicole C. T.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [7] Survey of Sexual Health Concerns among Patients with Treatment-Na ve Prostate Cancer
    Tam, A.
    Huang, Z.
    Gonzalez, E. Lopez
    Abuali, T.
    Correnti, N.
    DeWees, T. A.
    Maroongroge, S.
    Eastman, B.
    Glaser, S. M.
    Dandapani, S.
    Lee, P.
    Wong, J. Y. C.
    Chan, K.
    Lau, C.
    Yip, W.
    Dorff, T. B.
    Li, Y. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E402 - E402
  • [8] Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer
    Yasushi Goto
    Ikuo Sekine
    Maki Tanioka
    Takashi Shibata
    Chiharu Tanai
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Hideo Kunitoh
    Yuichiro Ohe
    Hironori Kikkawa
    Emiko Ohki
    Tomohide Tamura
    Investigational New Drugs, 2012, 30 : 1548 - 1556
  • [9] Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer
    Chen, Shang-Hung
    Tse, Ka-Po
    Lu, Yen-Jung
    Chen, Shu-Jen
    Tian, Yu-Feng
    Tan, Kien Thiam
    Li, Chien-Feng
    CANCER MEDICINE, 2024, 13 (12):
  • [10] The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
    Noemi Pavo
    Henrike Arfsten
    Anna Cho
    Georg Goliasch
    Philipp E. Bartko
    Raphael Wurm
    Claudia Freitag
    Heinz Gisslinger
    Gabriela Kornek
    Guido Strunk
    Markus Raderer
    Christoph Zielinski
    Martin Hülsmann
    Scientific Reports, 9
12345